Search
NRX Pharmaceuticals Inc
NRXPAdd to Watchlist
2.440USD
+0.080+3.39%
Close 11-11 16:00（ET）
105.65MMarket Cap
LossP/E TTM
Pre-market 07:07 (ET)2.450USD+0.010+0.41%
Pre-market 07:07 (ET)Today
+3.39%
5 Days
-2.01%
1 Month
-14.39%
6 Months
-13.48%
Year to Date
-9.96%
1 Year
-2.01%
Key Figures
2.390Open
2.500High
140.54KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.33%Turnover Ratio
2.360Prev. Close
2.360Low
344.12KTurnover
LossP/E Static
-618.93P/B
0.00%Div Yield TTM
-251.78%ROA
5.05552wk High
0.18Volume Ratio
-25.13MNet Profit
43.30MShares
-1.0457EPS TTM
2.12Beta
-682.81%ROE
1.62052wk Low
8.90%Amplitude
33.61%Gross Margin
105.65MMarket Cap
-4.18Reward/Risk
5.50%Risk Rate
NRX Pharmaceuticals Inc's Score
0.07vs previous score
Forecast8.40
Financial Health6.05
Technical4.98
Valuation Dimensions9.70
Institutional Confidence3.00
Risk Assessment3.76
Media Coverage
Coverage Level
Very Low
Very High
Positive+
Analyst Rating
NRX Pharmaceuticals Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Sell
NRX Pharmaceuticals Inc Latest Earnings Call Transcripts
NRx Pharmaceuticals (NRXP) Q2 2026 Earnings Call: ANDA Progress and $26.7M Cash
NRx Pharmaceuticals’ Q2 2026 earnings call covered $26.7 million in cash, KETAFREE FDA progress, the SPARC-TMS trial and GeNeuro’s ALS program.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.44/0.06
Revenue / Forecast
1.10M/16.56M
NRX Pharmaceuticals Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolNRXP
Number of employees0
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Anson Funds Management LP. | 9.21% |
| B Group, Inc. | 9.07% |
| Javitt (Jonathan C) | 4.59% |
| Vanguard Capital Management, LLC | 3.51% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 16.89% |
| Hedge Fund | 9.31% |
| Individual Investor | 5.39% |
| Corporation | 2.91% |
Related Instruments
+0.35%
-0.13%
+0.37%
-0.59%
-1.80%
-0.69%
+0.62%
-0.67%
+0.96%
+0.31%
-0.16%
+0.18%
-0.26%
+0.41%
-1.23%
-0.85%
+4.73%
-0.43%
+0.24%
+0.62%
FAQs
What is the current price of NRX Pharmaceuticals Inc (NRXP)?
The current price of NRX Pharmaceuticals Inc (NRXP) is 2.44.
What is the symbol of NRX Pharmaceuticals Inc?
The ticker symbol of NRX Pharmaceuticals Inc is NRXP.
What is the 52-week high of NRX Pharmaceuticals Inc?
The 52-week high of NRX Pharmaceuticals Inc is 5.05.
What is the 52-week low of NRX Pharmaceuticals Inc?
The 52-week low of NRX Pharmaceuticals Inc is 1.62.
What is the market capitalization of NRX Pharmaceuticals Inc?
The market capitalization of NRX Pharmaceuticals Inc is 105.65M.
Is NRX Pharmaceuticals Inc (NRXP) currently rated as Buy, Hold, or Sell?
According to analysts, NRX Pharmaceuticals Inc (NRXP) has an overall rating of Buy, with a price target of 38.50.
What is the Earnings Per Share (EPS TTM) of NRX Pharmaceuticals Inc (NRXP)?
The Earnings Per Share (EPS TTM) of NRX Pharmaceuticals Inc (NRXP) is -1.05.